About this trial
Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of cancer treatment that causes numbness, pain, and balance issues in a patient's hands and feet. This study focuses on finding a non-drug approach to help cancer survivors manage these uncomfortable symptoms.
The main purpose of this research is to evaluate whether combining Electroacupuncture(EA) with a exercise training program works better than using electroacupuncture alone. Electroacupuncture uses gentle electrical pulses through acupuncture needles to stimulate nerves, while the exercise program aims to improve a patient's balance, physical strength, and movement safety.
Participants will be randomly assigned to receive either the combination therapy or electroacupuncture alone. The study involves scheduled hospital visits along with home-based practice guided by instructional videos. The researchers aim to evaluate the efficacy of combined EA and exercise training program on neurological symptoms and quality of life in CIPN patients across different CTCAE grades.
Eligibility criteria
Qualifiers
Confirmed cancer diagnosis with prior taxane or platinum-based chemotherapy.
CIPN symptoms staged as CTCAE Grade 1, 2, or 3.
Life expectancy > 6 months and capable of independent ambulation.
Disqualifiers
Presence of a cardiac pacemaker.
Severe coagulation disorders.
Neuropathy from other etiologies (non-chemotherapy induced).
Trial design
Treatments tested in this trial
- Electroacupuncture
- Exercise Training
- Structured Home-Based Health Education and Dose-Controlled Exercise Program
- General Health Education